Cell Labeling Molecule for Non-Destructive Nucleic Acid Association

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing cell labeling methods fail to associate non-destructive information with nucleic acid sequences, especially when multiple cells are present in a compartment, leading to mixed nucleic acids and difficulty in distinguishing individual cell information, particularly for adherent cells or cells within tissues.

Innovation Solution

A cell labeling molecule comprising a particle with an identifiable property, an identification sequence, a cleavable linker, and a binding molecule that can bind to cells, allowing for the association of non-destructive information with nucleic acid sequences through optical detection and isolation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If a cell is lysed in a compartment to extract nucleic acid, then the nucleic acid can be obtained for analysis, but the non-destructive information of the cell is lost and cannot be associated with the nucleic acid sequence

Engineering Contradiction:
Improvenucleic acidVSAvoidnon-destructive information
Core Design Contradiction:
Quantity of substanceVSLoss of information

Solution Approach 1:

The invention divides the cell processing into separate compartments: one compartment for non-destructive imaging to capture non-destructive information, and another compartment for lysis to extract nucleic acid. The cell is physically segmented between these two functional zones, allowing both information types to be obtained without interference.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The non-destructive imaging is performed before the cell is lysed. By capturing the non-destructive information in advance, the system ensures that this information is preserved and can be subsequently associated with the nucleic acid sequence obtained after lysis, rather than losing it during the extraction process.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If more than one cell is placed in a compartment for analysis, then the throughput is improved, but the nucleic acids of multiple cells mix up and individual cell information cannot be distinguished

Engineering Contradiction:
ImprovethroughputVSAvoidindividual cell information
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The invention uses multiple separate compartments instead of a single compartment to hold multiple cells. Each compartment contains at most one cell, preventing nucleic acid mixing. The compartmentalization strategy segments the sample population into individual processing units, maintaining both high throughput and individual cell resolution.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses beads with identification sequences that serve as proxies or copies for identifying individual cells. Each bead is associated with a specific cell through co-localization in a compartment, and the bead's identification sequence allows tracking and association of that cell's non-destructive information with its nucleic acid sequence, even after the cell is lysed.

Inventive Principle:
Principle #26Copying

3Adaptability or versatility

If adherent cells or cells within tissues are analyzed, then clinically relevant samples can be studied, but it is difficult to place them in compartments for standard analysis

Engineering Contradiction:
Improvesample typeVSAvoidcompartment placement
Core Design Contradiction:
Adaptability or versatilityVSEase of operation

Solution Approach 1:

The invention changes the physical state or form of the sample by using tissue dissociation reagents to convert tissue samples into suspensions of individual cells. This parameter change (from intact tissue to cell suspension) enables the cells to be properly distributed into compartments for analysis, while still preserving the ability to study clinically relevant samples.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20240393342A1Cell labeling molecule and method for analyzing cell
Publication Date: 2024.11.28 RIKEN CO LTD
  • US20240393342A1 patent drawing
  • US20240393342A1 patent drawing
  • US20240393342A1 patent drawing

AI summary

A cell labeling molecule comprising a particle 101 having an identifiable property, an identification sequence 102 that is identifiable and corresponds to the property of the particle 101, a cleavable linker 103 that binds the particle 101 and the identification sequence 102, and a binding molecule 104 for binding to a cell, the binding molecule being bound to the identification sequence 102.